🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Outcomes for patients with severe aplastic anemia (SAA) who are refractory ...
Status
Recruiting
Location
CHU Amiens
Start Date
2022-01-06
Trial ID
NCT05126849
Treatments Being Tested
The aim of this study is to determine the maximal tolerated dose level of l...
Status
Completed
Location
Medizinische Universitaet Innsbruck, Abtlg. f. Haematologie und Onkologie
Start Date
2008-10
Trial ID
NCT00738829
Treatments Being Tested
This study is designed to evaluate the efficacy and safety of the current t...
Status
Unknown
Location
The Second Xiangya Hospital, Central South University
Start Date
2018-12-01
Trial ID
NCT03791827
Outcomes for adult patients with Severe Aplastic Anemia (SAA) aged more tha...
Status
Recruiting
Location
Saint Louis hospital
Start Date
2025-01-24
Trial ID
NCT06646497
Treatments Being Tested
This study will evaluate the safety and efficacy of the combination of ritu...
Status
Completed
Location
University Hospital Ghent
Start Date
2009-06
Trial ID
NCT00936546
Treatments Being Tested
Diffuse large B-cell lymphoma is the most prevalent subgroup within maligna...
Status
Completed
Location
Landeskrankenhaus Feldkirch
Start Date
2007-12
Trial ID
NCT00575406
Treatments Being Tested
This single arm study will evaluate the efficacy and safety of MabThera in ...
Status
Completed
Location
Multiple Locations
Start Date
2007-06
Trial ID
NCT00462345
Treatments Being Tested
The goal of this clinical trial is to study the addition of Acalabrutinib t...
Status
Recruiting
Location
Saarland University Medical Center
Start Date
2023-06-07
Trial ID
NCT05820841
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growt...
Status
Completed
Location
Universitaetsklinik fuer Innere Medizin I
Start Date
2005-10
Trial ID
NCT00275054
Treatments Being Tested
This is an open label, phase II study to evaluate the capacity of Rituximab...
Status
Completed
Location
AKH Linz
Start Date
2012-05
Trial ID
NCT01611259
Treatments Being Tested